Exhibit 10.11


 


springworks
therapeutics, INC.


 


EMPLOYMENT
AGREEMENT



 


This Employment Agreement (“Agreement”)
is made as of October 10, 2019, between SpringWorks Therapeutics, Inc., a Delaware corporation (the “Company”),
and Badreddin Edris (the “Employee”) and is effective as of the closing of the Company’s first underwritten
public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended
(the “Effective Date”).


 


WHEREAS, the Company or a subsidiary of
the Company and the Employee are parties to an offer letter, dated as of September 4, 2018, and a Severance Agreement, dated as
of September 10, 2018 (collectively, the “Prior Agreements”); and


 


WHEREAS, the parties intend to replace the
Prior Agreements with this Agreement, effective as of the Effective Date.


 


NOW, THEREFORE, in consideration of the
mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the parties agree as follows:


 


1.                 
Employment.


 


(a)              
Term. The term of this Agreement shall commence on the Effective Date and continue until terminated in accordance
with the provisions hereof (the “Term”). The Employee’s employment with the Company will continue to be
 “at will,” meaning that the Employee’s employment may be terminated by the Company or the Employee at any time
and for any reason subject to the terms of this Agreement.


 


(b)              
Position and Duties. During the Term, the Employee shall serve as the Chief Business Officer of the Company, and
shall have such duties and authorities as may from time to time be prescribed by the Chief Executive Officer of the Company (the
 “CEO”). The Employee shall devote his full working time and efforts to the business and affairs of the Company.
Notwithstanding the foregoing, the Employee may serve on other boards of directors, with the approval of the CEO, or engage in
religious, charitable or other community activities as long as such services and activities do not materially interfere with the
Employee’s performance of his duties to the Company as provided in this Agreement.


 






    


     


    

 


2.                 
Compensation and Related Matters.


 


(a)              
Base Salary. During the Term, the Employee’s annual base salary shall be $390,000. The Employee’s base
salary shall be reviewed annually by the Compensation Committee of the Board (the “Compensation Committee”).
The base salary in effect at any given time is referred to herein as “Base Salary.” The Base Salary shall be payable
in a manner that is consistent with the Company’s usual payroll practices.


 


(b)              
Incentive Compensation. During the Term, the Employee shall be eligible to receive cash incentive compensation as
determined by the Board or the Compensation Committee from time to time. The Employee’s initial target annual incentive compensation
shall be forty percent (40%) of his Base Salary (the “Target Annual Incentive Compensation”). The actual cash
incentive compensation payable to the Employee will be subject to the Board or Compensation Committee’s assessment of your
performance, as well as business conditions at the Company. Except as otherwise provided herein, to earn incentive compensation,
the Employee must be employed by the Company on the day such incentive compensation is paid.


 


(c)              
Expenses. The Employee shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by
him during the Term in performing services hereunder upon presentation of receipts and otherwise in accordance with the policies
and procedures then in effect and established by the Company.


 


(d)              
Other Benefits. During the Term, the Employee shall be eligible to participate in or receive benefits under the Company’s
employee benefit plans in effect from time to time, subject to the terms of such plans.


 


(e)              
Vacations. During the Term, the Employee shall be entitled to paid vacation in accordance with the Company’s
policies and procedures. The Employee shall also be entitled to all paid holidays given by the Company in accordance with the policies
and procedures then in effect and established by the Company.


 


3.                 
Termination. During the Term, the Employee’s employment hereunder may be terminated without any breach of this
Agreement under the following circumstances:


 


(a)              
Death. The Employee’s employment shall terminate upon his death.


 






    2


     


    

 


(b)               Termination
by Company for Cause. The Company may terminate the Employee’s employment for Cause. For purposes of this
Agreement, “Cause” shall mean that the Company has complied with the “Cause Process”
(hereinafter defined) following the occurrence of one of the following events: (i) conduct by the Employee constituting a
material act of misconduct in connection with the performance of his duties, including, without limitation, misappropriation
of funds or property of the Company or any of its subsidiaries or affiliates other than the occasional, customary and de
minimis use of Company property for personal purposes; (ii) the commission by the Employee of any felony or a misdemeanor
involving moral turpitude, deceit, dishonesty or fraud; (iii) any conduct by the Employee that would result in material
economic harm to the Company or any of its subsidiaries if he were retained in his position; (iv); a material breach by the
Employee of any provisions of this Agreement, including without limitation continued non-performance by the Employee of his
duties under this Agreement (other than by reason of the Employee’s physical or mental illness, incapacity or
disability) which has continued for more than 30 days following written notice of such non-performance from the Board; (v) a
material violation by the Employee of the Company’s employment policies provided to the Employee in writing; or (vi)
material failure to cooperate with a bona fide internal investigation by the Board or an investigation by regulatory or law
enforcement authorities, after being instructed by the Company to cooperate, or the willful destruction or failure to
preserve documents or other materials known to be relevant to such investigation or the inducement of others to fail to
cooperate or to produce documents or other materials in connection with such investigation (subject to the limitations in
the final sentence of Section 7(a)). If the Employee rebuts or cures the applicable finding of Cause within the applicable
cure period, Cause shall be deemed not to have occurred. “Cause Process” shall mean that: (A) the Board
reasonably determines in good faith that a “Cause” condition has occurred; and (B) with regard to any termination
of the Employee for Cause under items (i), (iii), (iv), (v) or (vi) above, (1) the Company will provide the Employee with
written notice of its intention to terminate the Employee’s employment hereunder setting forth with reasonable
particularity the basis for Cause and will provide the Employee with a thirty (30) day opportunity to rebut or cure such
finding of Cause and (2) the Company cooperates in good faith with the Employee’s efforts, for a period of not less
than 30 days following such notice to remedy the condition.


 


(c)              
Termination Without Cause. The Company may terminate the Employee’s employment at any time without Cause. Any
termination by the Company of the Employee’s employment which does not constitute a termination for Cause under Section 3(b)
and does not result from the death of the Employee under Section 3(a) shall be deemed a termination without Cause.


 






    3


     


    

 


(d)              
Termination by the Employee. The Employee may terminate his employment at any time for any reason, including but
not limited to Good Reason. For purposes of this Agreement, “Good Reason” shall mean that the Employee has complied
with the “Good Reason Process” (hereinafter defined) following the occurrence of any of the following events: (i) a
material diminution in the Employee’s title, responsibilities, authority or duties; (ii) a diminution in the Employee’s
base salary except for across-the-board salary reductions based on the Company’s financial performance similarly affecting
all senior management employees of the Company; (iii) a greater than fifty (50) mile change in the principal office location at
which the Employee provides services to the Company; or (iv) the material breach of any provisions of this Agreement by the Company.
 “Good Reason Process” shall mean that (i) the Employee reasonably determines in good faith that a “Good Reason”
condition has occurred; (ii) the Employee notifies the Company in writing of the occurrence of the Good Reason condition within
60 days of the Employee obtaining knowledge of the occurrence of such condition; (iii) the Employee cooperates in good faith with
the Company’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to
remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition continues to exist; and (v) the Employee terminates
his employment within 60 days after the end of the Cure Period. If the Company cures the Good Reason condition during the Cure
Period, Good Reason shall be deemed not to have occurred.


 


(e)              
Notice of Termination. Except for termination as specified in Section 3(a), any termination of the Employee’s
employment by the Company or any such termination by the Employee shall be communicated by written Notice of Termination to the
other party hereto. For purposes of this Agreement, a “Notice of Termination” shall mean a written notice which
shall indicate the specific termination provision in this Agreement relied upon Employee.


 


(f)                Date
of Termination. “Date of Termination” shall mean: (i) if the Employee’s employment is terminated
by his death, the date of his death; (ii) if the Employee’s employment is terminated by the Company under Section 3(c),
the date on which a Notice of Termination is given; (iii) if the Employee’s employment is terminated by the Employee
under Section 3(d) without Good Reason, the date on which a Notice of Termination is given, and (iv) if the
Employee’s employment is terminated by the Employee under Section 3(d) with Good Reason, the date on which a Notice of
Termination is given after the end of the Cure Period.


 






    4


     


    

 


4.                 
Compensation Upon Termination.


 


(a)              
Termination Generally. If the Employee’s employment with the Company is terminated for any reason, the Company
shall pay or provide to the Employee (or to his authorized representative or estate) (i) any base salary earned through the Date
of Termination, unpaid expense reimbursements (subject to, and in accordance with, Section 3(c) of this Agreement) and unused vacation
that accrued through the Date of Termination on or before the time required by law but in no event more than 30 days after the
Employee’s Date of Termination; and (ii) any vested benefits the Employee may have under any employee benefit plan of the
Company through the Date of Termination, which vested benefits shall be paid and/or provided in accordance with the terms of such
employee benefit plans (collectively, the “Accrued Benefit”).


 


(b)              
Termination by the Company Without Cause or by the Employee with Good Reason. If the Employee’s employment
is terminated by the Company without Cause as provided in Section 3(c), or the Employee terminates his employment for Good Reason
as provided in Section 3(d), then the Company shall pay the Employee his Accrued Benefit. In addition, subject to the Employee
signing a customary separation agreement containing, among other provisions, a general release of claims in favor of the Company,
its subsidiaries and affiliates, confidentiality, return of property and non-disparagement, in a form and substance mutually satisfactory
to the Company and the Employee (the “Separation Agreement and Release”) and the Separation Agreement and Release
becoming irrevocable and fully effective, all within 60 days after the Date of Termination (or such shorter time period provided
in the Separation Agreement and Release):


 


(i)                
the Company shall pay the Employee an amount equal to nine (9) months of the Employee’s Base Salary plus a pro-rata
payment (based on the number of days of the applicable fiscal year Employee was employed prior to termination) of the Employee’s
Target Annual Incentive Compensation (the “Severance Amount”). Notwithstanding the foregoing, if the Employee
breaches any of the provisions contained in Section 7 of this Agreement, all payments of the Severance Amount shall immediately
cease;


 


(ii)             
RESERVED;


 


(iii)           
if the Employee was participating in the Company’s group health plan immediately prior to the Date of Termination
and elects COBRA health continuation, then the Company shall pay to the Employee a monthly cash payment for nine (9) months or
the Employee’s COBRA health continuation period, whichever ends earlier, in an amount equal to the monthly employer contribution
that the Company would have made to provide health insurance to the Employee if the Employee had remained employed by the Company;
and


 






    5


     


    

 


(iv)            
the amounts payable under Section 4(b)(i) and (iii) shall be paid out in substantially equal installments in accordance
with the Company’s payroll practice commencing within 60 days after the Date of Termination; provided, however, that if the
60-day period begins in one calendar year and ends in a second calendar year, the Severance Amount shall begin to be paid in the
second calendar year by the last day of such 60-day period; provided, further, that the initial payment shall include a catch-up
payment to cover amounts retroactive to the day immediately following the Date of Termination. Each payment pursuant to this Agreement
is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2).


 


(c)              
The amounts payable pursuant to Section 4(a) and 4(b) are in addition to the provisions contained within any equity agreement
between the Company and the Employee, if applicable.


 


5.                 
Change in Control Payment. The provisions of this Section 5 set forth certain terms of an agreement reached between
the Employee and the Company regarding the Employee’s rights and obligations upon the occurrence of a Change in Control of
the Company. These provisions are intended to assure and encourage in advance the Employee’s continued attention and dedication
to his assigned duties and his objectivity during the pendency and after the occurrence of any such event. These provisions shall
apply in lieu of, and expressly supersede, the provisions of Section 4(b) regarding severance pay and benefits upon a termination
of employment, if such termination of employment occurs within 18 months after the occurrence of the first event constituting a
Change in Control. These provisions shall terminate and be of no further force or effect beginning 18 months after the occurrence
of a Change in Control.


 


(a)              
Change in Control. During the Term, if the Employee’s employment is terminated by the Company without Cause
as provided in Section 3(c) or the Employee terminates his employment for Good Reason as provided in Section 3(d), within three
(3) months prior to a Change in Control or within 18 months after a Change in Control, then, subject to the signing of the Separation
Agreement and Release by the Employee and the Separation Agreement and Release becoming irrevocable and fully effective, all within
60 days after the Date of Termination (or such shorter time period provided in the Separation Agreement and Release):


 


(i)                
the Company shall pay the Employee a lump sum in cash in an amount equal to the sum of (A) twelve (12) months of the Employee’s
Base Salary (or the Employee’s Base Salary in effect immediately prior to the Change in Control, if higher) plus (B) one
(1) times the Employee’s Target Annual Incentive Compensation (or the Employee’s Target Annual Incentive Compensation
in effect immediately prior to the Change in Control, if higher);


 


(ii)             
notwithstanding anything to the contrary in any applicable option agreement or stock-based award agreement, all time-based
stock options and other time-based stock-based awards held by the Employee shall immediately accelerate and become fully exercisable
or nonforfeitable as of the Date of Termination;


 






    6


     


    

 


(iii)           
if the Employee was participating in the Company’s group health plan immediately prior to the Date of Termination
and elects COBRA health continuation, then the Company shall pay to the Employee a monthly cash payment for twelve (12) months
or the Employee’s COBRA health continuation period, whichever ends earlier, in an amount equal to the monthly employer contribution
that the Company would have made to provide health insurance to the Employee if the Employee had remained employed by the Company;
and


 


(iv)            
The amounts payable under Section 5(a)(i) and (iii) shall be paid or commence to be paid within 60 days after the Date of
Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, such
payment shall be paid or commence to be paid in the second calendar year by the last day of such 60-day period.


 


(b)              
Additional Limitation.


 


(i)                
Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or
distribution by the Company to or for the benefit of the Employee, whether paid or payable or distributed or distributable pursuant
to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 280G of the Internal Revenue Code of
1986, as amended (the “Code”) and the applicable regulations thereunder (the “Aggregate Payments”),
would be subject to the excise tax imposed by Section 4999 of the Code, then the Aggregate Payments shall be reduced (but not below
zero) so that the sum of all of the Aggregate Payments shall be $1.00 less than the amount at which the Employee becomes subject
to the excise tax imposed by Section 4999 of the Code; provided that such reduction shall only occur if it would result in the
Employee receiving a higher After Tax Amount (as defined below) than the Employee would receive if the Aggregate Payments were
not subject to such reduction. In such event, the Aggregate Payments shall be reduced in the following order, in each case, in
reverse chronological order beginning with the Aggregate Payments that are to be paid the furthest in time from consummation of
the transaction that is subject to Section 280G of the Code: (1) cash payments not subject to Section 409A of the Code; (2) cash
payments subject to Section 409A of the Code; (3) equity-based payments and acceleration; and (4) non-cash forms of benefits; provided
that in the case of all the foregoing Aggregate Payments all amounts or payments that are not subject to calculation under Treas.
Reg. §1.280G-1, Q&A-24(b) or (c) shall be reduced before any amounts that are subject to calculation under Treas. Reg.
 §1.280G-1, Q&A-24(b) or (c).


 


(ii)              For
purposes of this Section 5(b), the “After Tax Amount” means the amount of the Aggregate Payments less
all federal, state, and local income, excise and employment taxes imposed on the Employee as a result of the Employee’s
receipt of the Aggregate Payments. For purposes of determining the After Tax Amount, the Employee shall be deemed to pay
federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year
in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual
taxation in each applicable state and locality, net of the maximum reduction in federal income taxes which could be obtained
from deduction of such state and local taxes.


 






    7


     


    

 


(iii)           
The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section 5(b)(i) shall be
made by a nationally recognized accounting firm selected by the Company (the “Accounting Firm”), which shall
provide detailed supporting calculations both to the Company and the Employee within 15 business days of the Date of Termination,
if applicable, or at such earlier time as is reasonably requested by the Company or the Employee. Any determination by the Accounting
Firm shall be binding upon the Company and the Employee.


 


(c)              
Definitions. For purposes of this Section 5, the following terms shall have the following meanings:


 


“Change in Control” shall mean
any of the following:


 


(i)                
any “person,” as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended
(the “Act”) (other than the Company, any of its subsidiaries, or any trustee, fiduciary or other person or entity
holding securities under any employee benefit plan or trust of the Company or any of its subsidiaries), together with all “affiliates”
and “associates” (as such terms are defined in Rule 12b-2 under the Act) of such person, shall become the “beneficial
owner” (as such term is defined in Rule 13d-3 under the Act), directly or indirectly, of securities of the Company representing
50 percent or more of the combined voting power of the Company’s then outstanding securities having the right to vote in
an election of the Board (“Voting Securities”) (in such case other than as a result of an acquisition of securities
directly from the Company); or


 


(ii)             
the date a majority of the members of the Board is replaced during any 12-month period by directors whose appointment or
election is not endorsed by a majority of the members of the Board before the date of the appointment or election; or


 


(iii)           
the consummation of (A) any consolidation or merger of the Company where the stockholders of the Company, immediately prior
to the consolidation or merger, would not, immediately after the consolidation or merger, beneficially own (as such term is defined
in Rule 13d-3 under the Act), directly or indirectly, shares representing in the aggregate more than 50 percent of the voting shares
of the Company issuing cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any), or (B)
any sale or other transfer (in one transaction or a series of transactions contemplated or arranged by any party as a single plan)
of all or substantially all of the assets of the Company and its affiliates on a consolidated basis.


 






    8


     


    

 


Notwithstanding the foregoing, a
 “Change in Control” shall not be deemed to have occurred for purposes of the foregoing clause (i) solely as the
result of an acquisition of securities by the Company which, by reducing the number of shares of Voting Securities
outstanding, increases the proportionate number of Voting Securities beneficially owned by any person to 50 percent or more
of the combined voting power of all of the then outstanding Voting Securities; provided, however, that if any person referred
to in this sentence shall thereafter become the beneficial owner of any additional shares of Voting Securities (other than
pursuant to a stock split, stock dividend, or similar transaction or as a result of an acquisition of securities directly
from the Company) and immediately thereafter beneficially owns 50 percent or more of the combined voting power of all of the
then outstanding Voting Securities, then a “Change in Control” shall be deemed to have occurred for purposes of
the foregoing clause (i).


 


6.                 
Section 409A.


 


(a)              
Anything in this Agreement to the contrary notwithstanding, if at the time of the Employee’s separation from service
within the meaning of Section 409A of the Code, the Company determines that the Employee is a “specified employee”
within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Employee becomes
entitled to under this Agreement on account of the Employee’s separation from service would be considered deferred compensation
otherwise subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application
of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date
that is the earlier of (A) six months and one day after the Employee’s separation from service, or (B) the Employee’s
death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up
payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision,
and the balance of the installments shall be payable in accordance with their original schedule.


 


(b)              
All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company
or incurred by the Employee during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively
practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year
in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year
shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except
for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits
is not subject to liquidation or exchange for another benefit.


 






    9


     


    

 


(c)              
To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation”
under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Employee’s termination
of employment, then such payments or benefits shall be payable only upon the Employee’s “separation from service.”
The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions
set forth in Treasury Regulation Section 1.409A-1(h).


 


(d)               The
parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any
provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in
such a manner so that all payments hereunder comply with Section 409A of the Code. Each payment pursuant to this Agreement
is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). The parties
agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply
with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided
hereunder without additional cost to either party.


 


(e)              
The Company makes no representation or warranty and shall have no liability to the Employee or any other person if any provisions
of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an
exemption from, or the conditions of, such Section.


 


7.                 
Confidential Information, Noncompetition and Cooperation. The terms of the Confidentiality and Proprietary Rights
Agreement (the “Restrictive Covenant Agreement”), between the Company or a subsidiary thereof and the Employee,
attached hereto as Exhibit A, shall continue to be in full force and effect and are incorporated by reference in this Agreement.
The Employee hereby reaffirms the terms of the Restrictive Covenant Agreement as material terms of this Agreement.


 






    10


     


    

 


(a)              
Litigation and Regulatory Cooperation. During and after the Employee’s employment, the Employee shall reasonably
cooperate with the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the
future against or on behalf of the Company which relate to events or occurrences that transpired while the Employee was employed
by the Company. The Employee’s cooperation in connection with such claims or actions shall include, but not be limited to,
being reasonably available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company
at mutually convenient times. During and after the Employee’s employment, the Employee also shall cooperate fully with the
Company in connection with any investigation or review of any federal, state or local regulatory authority as any such investigation
or review relates to events or occurrences that transpired while the Employee was employed by the Company. The Company shall reimburse
the Employee for any reasonable out-of-pocket expenses incurred in connection with the Employee’s performance of
obligations pursuant to this Section 7(a) upon presentation of receipts. Nothing about the foregoing shall preclude the Employee
from testifying truthfully in any forum or from providing truthful information to any regulatory authority or require the Employee
to waive any attorney-client privilege or protection or violate any applicable law.


 


(b)               Relief.
The Employee agrees that it would be difficult to measure any damages caused to the Company which might result from any
breach by the Employee of the promises set forth in this Section 7, and that in any event money damages would be an
inadequate remedy for any such breach. Accordingly, subject to Section 8 of this Agreement, the Employee agrees that if the
Employee breaches, or proposes to breach, any portion of this Agreement, the Company shall be entitled, in addition to
all other remedies that it may have, to an injunction or other appropriate equitable relief to restrain any such breach
without showing or proving any actual damage to the Company. In addition, in the event the Employee breaches this Section 7
during a period when he is receiving severance payments pursuant to Section 4 or Section 5 hereof, the Company shall have the
right to suspend or terminate such severance payments. Such suspension or termination shall not limit the Company’s
other options with respect to relief for such breach and shall not relieve the Employee of his duties under this
Agreement.


 


(c)              
Protected Disclosures and Other Protected Action. Nothing contained in this Agreement limits the Employee’s
ability to communicate with any federal, state or local governmental agency or commission, including to provide documents or other
information, without notice to the Company.


 






    11


     


    

 


8.                 
Arbitration of Disputes. Any controversy or claim arising out of or relating to this Agreement or the breach thereof
or otherwise arising out of the Employee’s employment or the termination of that employment (including, without limitation,
any claims of unlawful employment discrimination whether based on age or otherwise) shall, to the fullest extent permitted by law,
be settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an agreement, under the auspices
of the American Arbitration Association (“AAA”) in Stamford, Connecticut, in accordance with the Employment
Dispute Resolution Rules of the AAA, including, but not limited to, the rules and procedures applicable to the selection of arbitrators.
In the event that any person or entity other than the Employee or the Company may be a party with regard to any such controversy
or claim, such controversy or claim shall be submitted to arbitration subject to such other person or entity’s agreement.
Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. This Section 8 shall
be specifically enforceable. Notwithstanding the foregoing, this Section 8 shall not preclude either party from pursuing a court
action for the sole purpose of obtaining a temporary restraining order or a preliminary injunction in circumstances in which such
relief is appropriate; provided that any other relief shall be pursued through an arbitration proceeding pursuant to this Section
8.


 


9.                 
Consent to Jurisdiction. To the extent that any court action is permitted consistent with or to enforce Section 8
of this Agreement, the parties hereby consent to the jurisdiction of the courts of the State of Connecticut and the United States
District Court for the District of Connecticut. Accordingly, with respect to any such court action, the Employee (a) submits to
the personal jurisdiction of such courts; (b) consents to service of process; and (c) waives any other requirement (whether imposed
by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.


 


10.             
Integration. This Agreement constitutes the entire agreement between the parties with respect to the subject matter
hereof and supersedes all prior agreements between the parties concerning such subject matter, including the Prior Agreement.


 


11.             
Withholding. All payments made by the Company to the Employee under this Agreement shall be net of any tax or other
amounts required to be withheld by the Company under applicable law.


 


12.              Successor
to the Employee. This Agreement shall inure to the benefit of and be enforceable by the Employee’s personal
representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of the
Employee’s death after his termination of employment but prior to the completion by the Company of all payments due to
him under this Agreement, the Company shall continue such payments to the Employee’s beneficiary designated in writing
to the Company prior to his death (or to his estate, if the Employee fails to make such designation).


 






    12


     


    

 


13.             
Enforceability. If any portion or provision of this Agreement (including, without limitation, any portion or provision
of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction,
then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which
it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall
be valid and enforceable to the fullest extent permitted by law.


 


14.             
Survival. The provisions of this Agreement shall survive the termination of this Agreement and/or the termination
of the Employee’s employment to the extent necessary to effectuate the terms contained herein.


 


15.             
Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party.
The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of
any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of
any subsequent breach.


 


16.             
Notices. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient
if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified
mail, postage prepaid, return receipt requested, to the Employee at the last address the Employee has filed in writing with the
Company or, in the case of the Company, at its main offices, attention of the Board.


 


17.             
Amendment. This Agreement may be amended or modified only by a written instrument signed by the Employee and by a
duly authorized representative of the Company.


 


18.             
Governing Law. This is a Connecticut contract and shall be construed under and be governed in all respects by the
laws of the State of Connecticut without giving effect to the conflict of laws principles thereof.


 


19.             
Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered
shall be taken to be an original; but such counterparts shall together constitute one and the same document.


 


20.             
Successor to Company. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation
or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and agree to perform this
Agreement to the same extent that the Company would be required to perform it if no succession had taken place. Failure of the
Company to obtain an assumption of this Agreement at or prior to the effectiveness of any succession shall be a material breach
of this Agreement.


 


21.             
Gender Neutral. Wherever used herein, a pronoun in the masculine gender shall be considered as including the feminine
gender unless the context clearly indicates otherwise.


 






    13


     


    

 


IN WITNESS WHEREOF, the parties have executed
this Agreement effective on the date and year first above written.


 


	 	SPRINGWORKS THERAPEUTICS, INC.
	 
	 	By:	/s/ Saqib Islam
	 	Its:	Chief Executive Officer




 


	 	EMPLOYEE
	 
	 	/s/ Badreddin Edris
	 	Badreddin Edris




 


 



    14